These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9839101)

  • 1. Isradipine in prediabetic hypertensive subjects.
    Byington RP; Furberg CD; Craven TE; Pahor M; Sowers JR
    Diabetes Care; 1998 Dec; 21(12):2103-10. PubMed ID: 9839101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial.
    Borhani NO; Mercuri M; Borhani PA; Buckalew VM; Canossa-Terris M; Carr AA; Kappagoda T; Rocco MV; Schnaper HW; Sowers JR; Bond MG
    JAMA; 1996 Sep; 276(10):785-91. PubMed ID: 8769587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrochlorothiazide is superior to isradipine for reduction of left ventricular mass: results of a multicenter trial. The Isradipine Study Group.
    Papademetriou V; Gottdiener JS; Narayan P; Cushman WG; Zachariah PK; Gottdiener PS; Chase GA
    J Am Coll Cardiol; 1997 Dec; 30(7):1802-8. PubMed ID: 9385910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIDAS, the Multicenter Isradipine/Diuretic Atherosclerosis Study. Design features and baseline data.
    Applegate WB; Byington RP
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):114S-117S. PubMed ID: 1827000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of antihypertensive drug effects on the progression of extracranial carotid atherosclerosis. The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS).
    Grimm RH; Flack JM; Byington R; Bond G; Brugger S
    Drugs; 1990; 40 Suppl 2():38-43. PubMed ID: 2150640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of rilmenidine compared with isradipine in hypertensive patients with features of metabolic syndrome.
    Widimský J; Sirotiaková J
    Curr Med Res Opin; 2006 Jul; 22(7):1287-94. PubMed ID: 16834827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter isradipine diuretic atherosclerosis study (MIDAS). Design features. The Midas Research Group.
    Furberg CD; Byington RP; Borhani NA
    Am J Med; 1989 Apr; 86(4A):37-9. PubMed ID: 2523653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MIDAS: hypertension and atherosclerosis. A trial of the effects of antihypertensive drug treatment on atherosclerosis. MIDAS Research Group.
    Borhani NO; Miller ST; Brugger SB; Schnaper HW; Craven TE; Bond MG; Khoury S; Flack J
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S16-20. PubMed ID: 1376828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing.
    Pelttari LH; Hietanen EK; Salo TT; Kataja MJ; Kantola IM
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):272-9. PubMed ID: 9544866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension.
    Agrawal R; Marx A; Haller H
    J Hypertens; 2006 Jan; 24(1):185-92. PubMed ID: 16331117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic effects of isradipine versus hydrochlorothiazide in diabetes mellitus.
    Klauser R; Prager R; Gaube S; Gisinger C; Schnack C; Küenburg E; Schernthaner G
    Hypertension; 1991 Jan; 17(1):15-21. PubMed ID: 1824760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Multicenter Isradipine/Diuretic Atherosclerosis Study: a study of the antiatherogenic properties of isradipine in hypertensive patients. MIDAS Research Group.
    Borhani NO; Bond MG; Sowers JR; Canossa-Terris M; Buckalew V; Gibbons ME; Worthy AJ
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S15-9. PubMed ID: 1720479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crossover comparison of atenolol, enalapril, hydrochlorothiazide and isradipine for isolated systolic systemic hypertension.
    Silagy CA; McNeil JJ; McGrath BP
    Am J Cardiol; 1992 Nov; 70(15):1299-305. PubMed ID: 1442581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of enalapril and isradipine alone and in combination on blood pressure, renal function and echocardiographic parameters in mild hypertension.
    De Rosa ML; Maddaluno G; Lionetti F; Di Palma U; Albanese L; Cardace P; Baiano A; Vigorito C
    Int J Cardiol; 2000 Jun; 74(1):77-84. PubMed ID: 10854683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of left ventricular mass by short-term antihypertensive treatment with isradipine: a double-blind comparison with enalapril.
    Galderisi M; Celentano A; Garofalo M; Tammaro P; Oliviero M; Petrocelli A; de Divitiis O
    Int J Clin Pharmacol Ther; 1994 Jun; 32(6):312-6. PubMed ID: 7921533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium antagonists and atherosclerosis. The Multicenter Isradipine/Diuretic Atherosclerosis Study.
    Furberg CD; Borhani NO; Byington RP; Gibbons ME; Sowers JR
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):24S-29S. PubMed ID: 8466723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antihypertensive effect and adverse effects of isradipine in patients with sever hypertension. Results of an open multicenter study].
    Burger KJ; Dehner R
    Arzneimittelforschung; 1996 Jun; 46(6):600-5. PubMed ID: 8767350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channel blockade (isradipine) in treatment of hypertension in pregnancy: a randomized placebo-controlled study.
    Wide-Swensson DH; Ingemarsson I; Lunell NO; Forman A; Skajaa K; Lindberg B; Lindeberg S; Marsàl K; Andersson KE
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):872-8. PubMed ID: 7573260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of atenolol, enalapril, and isradipine in elderly hypertensive women.
    Perry HM; Hall WD; Benz JR; Bartels DW; Kostis JB; Townsend RR; Due DL; Peng A; Sirgo M
    Am J Med; 1994 Jan; 96(1):77-86. PubMed ID: 8304366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MIDAS: rationale, design and descriptive data of trial patients. The MIDAS Research Group.
    Borhani NO
    Blood Press Suppl; 1994; 1():29-35. PubMed ID: 8205295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.